Rectus sheath haematoma: experience in our center

被引:0
作者
Povar, M. [1 ]
Lasala, M. [1 ]
Ruiz, A. [1 ]
Povar, B. J. [1 ]
机构
[1] Hosp Univ Miguel Servet, Zaragoza, Spain
关键词
Spontaneous rectus sheath hematoma; Abdominal wall disease; Anticoagulant therapy; Transcatheter embolization; Abdominal pain; NONVALVULAR ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; COST-EFFECTIVENESS; STROKE PREVENTION; DABIGATRAN; MANAGEMENT; RIVAROXABAN; APIXABAN; WARFARIN; RISK;
D O I
10.23938/ASSN.0044
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. To describe the clinical characteristics of patients diagnosed with spontaneous abdominal rectus muscle hematoma (RSH), predisposing and precipitating factors, and therapeutic management. Method. Retrospective descriptive study of 46 RSH diagnosed from 2002 to 2016. Epidemiological, clinical, diagnostic tests and treatment were analyzed. Results. The median age of patients was 81 years, 61% were female. The most frequent triggers were persistent coughing and injection of low molecular weight heparin. Seventy percent were anticoagulated, of which 57% had INR in the supratherapeutic range, and in 45% anticoagulation was definitively discontinued after admission. Forty-one percent presented chronic renal failure; moreover, creatinine at the time of diagnosis was higher than baseline (p <0.001). In most cases, treatment was conservative; interventional radiology was performed on three patients (6.5%) and open surgery on four (8.7%). Invasive treatment was employed with patients who had larger hematomas and higher transfusion requirements, and this was associated with a longer mean stay (p<0.001). Conclusions. RSH is more frequent in elderly patients, treated with acenocumarol and in the supratherapeutic range, and frequently entails permanent suspension of anticoagulant therapy. Renal insufficiency is related to the overdosage of the anticoagulant treatment and to the production of the hematoma. The size of RSH and transfusion requirements are factors that seem to be related to a greater need for invasive treatment through arterial embolization or surgery.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 50 条
  • [43] Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center
    Xue, Xin
    Jiang, Lisheng
    Duenninger, Erich
    Muenzel, Manuela
    Guan, Shaofeng
    Fazakas, Adam
    Cheng, Fanzhou
    Illnitzky, Juergen
    Keil, Thorsten
    Yu, Jiangtao
    HEART AND VESSELS, 2018, 33 (09) : 1068 - 1075
  • [44] Spontaneous Rectus Sheath Hematoma in Pregnancy: A Case Report
    Machado-Gedeon, Alexandre
    Mitric, Cristina
    Ponette, Vincent
    Benjamin, Alice
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2020, 42 (11) : 1388 - 1390
  • [45] Nephrotic syndrome with rectus sheath hematoma: a case report
    Fujii, Ai
    Matsuda, Yuto
    Yabe, Tomohisa
    Norifumi, Hayashi
    Fujimoto, Keiji
    Yamazaki, Masahide
    Yokoyama, Hitoshi
    Furuichi, Kengo
    JOURNAL OF MEDICAL CASE REPORTS, 2024, 18 (01)
  • [47] Spontaneous rectus sheath hematoma in patients on anticoagulation therapy
    Dag, Ahmet
    Ozcan, Turkay
    Turkmenoglu, Ozgur
    Colak, Tahsin
    Karaca, Kerem
    Canbaz, Hakan
    Dirlik, Musa
    Saribay, Ramazan
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2011, 17 (03): : 210 - 214
  • [48] Spontaneous rectus sheath hematoma: an analysis of 15 cases
    Carkman, Sinan
    Ozben, Volkan
    Zengin, Kagan
    Somuncu, Erkan
    Karatas, Adem
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2010, 16 (06): : 532 - 536
  • [49] Nephrotic syndrome with rectus sheath hematoma: a case report
    Ai Fujii
    Yuto Matsuda
    Tomohisa Yabe
    Hayashi Norifumi
    Keiji Fujimoto
    Masahide Yamazaki
    Hitoshi Yokoyama
    Kengo Furuichi
    Journal of Medical Case Reports, 18
  • [50] Spontaneous rectus sheath hematoma in a patient treated with apixaban
    Aktas, Halil
    Inci, Sinan
    Dogan, Pinar
    Izgu, Ibrahim
    INTRACTABLE & RARE DISEASES RESEARCH, 2016, 5 (01) : 47 - 49